| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | EP1430144A4 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 02/01/2006 | EP1425281B1 Tricyclic CRF receptor antagonists |
| 02/01/2006 | EP1212376B1 Synthetic vegetal melanins, process for their production and compositions containing them |
| 02/01/2006 | EP1200479B1 Multiple cytokine-antibody complexes |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 02/01/2006 | EP1158968B1 Jak-3 inhibitors for treating allergic disorders |
| 02/01/2006 | EP1146894B1 Uses of thank protein, a tnf homologue, to inhibit growth of tumour cells |
| 02/01/2006 | EP1133315B1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | EP1066052B1 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 02/01/2006 | EP1064402B1 Antisense modulation of lfa-3 |
| 02/01/2006 | EP0956040B1 Stimulation of host defense mechanisms against viral challenges |
| 02/01/2006 | EP0907736B1 Cc-type chemokines |
| 02/01/2006 | EP0906119B1 Stimulation of host defense mechanisms against cancer |
| 02/01/2006 | EP0898478B1 Stimulation of host defence mechanisms against tumors |
| 02/01/2006 | EP0859613B1 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 02/01/2006 | CN1729191A Pyrazoloquinolines with immunomodulating activity |
| 02/01/2006 | CN1729186A Piperidine derivatives useful as CCR5 antagonists |
| 02/01/2006 | CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | CN1729180A Piperazinyl and diazapanyl benzamides and benzthioamides |
| 02/01/2006 | CN1727359A Compound from catarrh mollase bacterial |
| 02/01/2006 | CN1726961A Essential oils for treating and/or preventing allergic disease |
| 02/01/2006 | CN1726885A Bracket for eluting TINI based medication and preparation method |
| 02/01/2006 | CN1239694C Space mutagenesis high production and highly performance bacterial and use thereof |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 01/31/2006 | USRE38962 Diphenyl-triazole derivatives and their use as anti-gestative immuno-suppressant and anti-tumoral agents |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992189 Such as 4-((Z)-(4-bromophenyl)(ethoxyimno)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; for the treatment of AIDS and related HIV infections |
| 01/31/2006 | US6992176 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 01/31/2006 | US6992095 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 01/31/2006 | US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | US6992082 for treatment of cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation |
| 01/31/2006 | US6992074 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/31/2006 | US6992068 Brazilian licorice extract and periandrins, which are constituents thereof, have an anti inflammatory effect and an immunosuppressive effect |
| 01/31/2006 | US6991817 Acid-modified arabinogalactan protein composition |
| 01/31/2006 | US6991785 Administering by tissue absorption |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2150806C Antiallergic triazolobenzazepine derivatives |
| 01/26/2006 | WO2006009325A1 Metalloprotease inhibitor |
| 01/26/2006 | WO2006009309A1 Galectin 9-binding protein factor |
| 01/26/2006 | WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | WO2006008881A1 Peroral vaccine carrier system |
| 01/26/2006 | WO2006007680A1 Pharmaceutical compositions from carapa guianensis |
| 01/26/2006 | WO2004096798A3 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019988 Compounds, compositions, and methods |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019958 Immunity-related protein kinase inhibitors |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060019246 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases |
| 01/26/2006 | US20060018915 Heteroclitic analogs and related methods |
| 01/26/2006 | US20060018898 Antibody variants |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | CA2574665A1 Therapeutic and diagnostic agents |
| 01/26/2006 | CA2574228A1 Acute inflammatory condition treatment |
| 01/26/2006 | CA2574188A1 Anti-histaminic composition |
| 01/26/2006 | CA2574060A1 Immune modulating compounds from fungi |
| 01/26/2006 | CA2573245A1 Multivalent vla-4 antagonists comprising polymer moieties |
| 01/26/2006 | CA2570817A1 Azaindoles modulating c-kit activity and uses therefor |
| 01/26/2006 | CA2570602A1 Agents for regulating the activity of interferon-producing cells |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619205A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/25/2006 | EP1619203A1 Galectin 9-inducing factor |
| 01/25/2006 | EP1619199A1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 01/25/2006 | EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1618892A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618891A1 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor |
| 01/25/2006 | EP1618884A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618879A1 Injectable formulations of taxanes for cad treatment |
| 01/25/2006 | EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617872A2 Methods and compositions for enhancing immune response |
| 01/25/2006 | EP1617868A1 Vav inhibition in graft rejection |
| 01/25/2006 | EP1617867A1 Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617837A1 Composition for preventing or treating allergic disease using black rice extract and its therapeutic use |
| 01/25/2006 | EP1617810A2 Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 01/25/2006 | EP1617807A2 Substituted 1,4-diazepines and uses thereof |
| 01/25/2006 | EP1617806A2 Selective spirocyclic glucocorticoid receptor modulators |
| 01/25/2006 | EP1617803A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 01/25/2006 | EP1513826B1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents |